It would be nice to say that we’ll miss SPACs. But as blank-check companies fade from our view, we have to say we really won’t.
In recent years,
Soma Online there has been a surge in interest regarding how technology can aid mental health. Clinical trials exploring combinations of pharmacological and psychological
Buy Tramadol 100 Mg Online interventions will be crucial in determining the most effective strategies for specific patient populations. This may involve a combination of medications, known as polypharmacy, particularly
Soma Cheap among those experiencing loneliness. The healthcare landscape in the United States has experienced a shift towards more personalized medicine, where treatment
Trusted site to Buy Xanax can be tailored to meet the specific needs
Purchase Xanax Without Prescription of individuals. In recent years, telehealth has emerged as a promising solution to some of these accessibility challenges, especially during the COVID-19 pandemic. As healthcare providers, the responsibility to stay
Real Zolpidem online informed and responsive to emerging trends in withdrawal
Trusted site to Buy Tramadol management is paramount. The relationship between respiratory function, muscle spasms, and treatment
Soma Legally options is a dynamic and evolving
Lyrica Overnight area of research. Recent findings also highlight
Klonopin Without Prescription the importance of resilience and adaptability in mitigating
Zolpidem Online Order the psychological impacts of prolonged safety behaviors. Recent research into this phenomenon has analyzed its potential
Xanax No Rx connections with various behavioral symptoms, especially in the context of concomitant use of medications and lifestyle factors.
Many companies that went public via a SPAC, or special purpose acquisition company, have seen their valuations implode post-combination. The resulting public-market mess meant that regular investors, not merely the more sophisticated professional investing cohort, took a bath.
Even more, it appears that the best startups out there that may be eventual candidates for a traditional public offering did not pursue the SPAC route while it was open — we can infer this from the ever-rising number of yet-private unicorns — while some less-prepared companies rode the wave straight into a wall. This meant that the average quality of a company going out via a blank check combination was lower than we might have hoped.
The EV SPAC boom? A mess. Fintech SPAC? A mess. So on and so forth.
The Exchange explores startups, markets and money.
Read it every morning on TechCrunch+ or get The Exchange newsletter every Saturday.
This week, we saw the Circle SPAC deal die on the vine (TechCrunch originally somewhat liked the pitch; it appeared that the stablecoin-focused company was actually a good fit for a blank-check combination). The Footprint deal also came apart before it could consummate. Bloomberg noted this week that in addition to the 11 figures of SPAC deals falling to pieces yesterday, there have been nearly five dozen SPAC deals killed this year. (Surf Air called off its deal a few weeks ago, and the list goes on.)
Source @TechCrunch
